Skip to main content
ACR Convergence 2025 Main banner
Final Program


Schedule at a Glance
Legend

Scientific Session

Interstitial Lung Disease

Session: The Many Faces of ILD in Rheumatic Diseases

Personalized Treatment for SARD-ILD: Combining Clinical and Biological Features to Inform Management Decisions

Monday, October 27, 2025
1:30 PM – 2:00 PM Central Time

    Speaker(s)

  • EW

    Erin Wilfong, MD, PhD

    Vanderbilt University Medical Center
    Nashville, Tennessee, United States

    Disclosure(s): Allogene: Consultant (Ongoing); AstraZeneca: Consultant (Ongoing); Boehringer-Ingelheim: Advisor or Review Panel Member (Ongoing), Consultant (Ongoing), Grant/Research Support (Ongoing); Capstan Therapeutics: Consultant (Ongoing); Merck/MSD: Advisor or Review Panel Member (Terminated, September 30, 2024); UpToDate: Royalties (Ongoing)